糖尿病肾脏疾病诊断治疗指南解读

1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification 2002(z1)
2. US Renal Data System USRDS 2004 Annual Data Report.The National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases 2004
3. Zimmet P.Alberti KG.Shaw J Global and societal implications of the diabetes epidemic 2001
4. National Kidney Foundation K/DOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease 2006(z2)
5. Warram JH.Gearin G.Laffel L Effect of duration of type Ⅰdiabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio 1996(3)
6. American Diabetes Association Standards of medical care in diabetes-2007 2007(z1)
7. Go RC.Desmond R.Roseman JM Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes 2001(6)
8. Wachtell K.Palmieri V.Olsen MH Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy:the LIFE Study.Losartan Intervention for Endpoint Reduction 2002(2)
9. Lewis JB.Berl T.Bain RP Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy.Collaborative Study Group 1999(5)
10. Bakris GL.Slataper R.Vicknair N ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive,diabetic subjects 1994(1)
11. Parving HH.Hovind P Microalbuminuria in type 1 and type 2 diabetes mellitus:evidence with angiotensin converting enzyme inhibitors and angiotensin Ⅱ receptor blockers for treating early and preventing clinical nephropathy 2002(3)
12. Brenner BM.Cooper ME.de Zeeuw D Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy 2001(5)
13. Lewis EJ.Hunsicker LG.Clarke WR Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes 2001
14. Estacio RO.Jeffers BW.Gifford N Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes 2000(Sl2)
15. Melian EB.Jarvis B Candesartan cilexetil plus hydrochlorothiazide combination:a review of its use in hypertension 2002(7)
16. Weir MR.Smith DH.Neutel JM Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives:relation to salt intake 2001(5)
17. Wanner C.Krane V.Marz W Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study):demographic and baseline characteristics 2004(2)
18. National Kidney Foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure 2000(z2)

更多...

1. 方文华 糖尿病肾病的药物治疗 [期刊论文] -安徽医药2009(2)

更多...